By Shah Gilani
Email – #42
**Right Place Right Time
Dear Reader,
We bought Medarex (MEDX) on April 23, 2009 based on Trigger Events that signaled the company as a compelling buy. We were rewarded yesterday when another of our Trigger Event holdings (itself a candidate for takeover) Bristol Myers Squib Co. (BMY) stepped up and decided to takeover MEDX [...]
Log in below to read the full article.
Please Log In
Type your username and password into the form below.